These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11871314)

  • 1. [Modern methods of detection of HIV resistance to the action of anti-retroviral agents].
    Bobkova MR
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):90-100. PubMed ID: 11871314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV drug resistance and laboratory methods for its detection (Lecture)].
    Bobkova MR
    Klin Lab Diagn; 2002 Jan; (1):25-32. PubMed ID: 11855336
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental and clinical research of HIV-1 resistance in three AIDS patients who had experienced multiple regimens.
    Lu JF; Li J; Li HP; Liu SY; Zhuang DM; Liu YJ; Bao ZY; Li L; Wu H; Li JY
    Chin Med J (Engl); 2009 Mar; 122(6):752-4. PubMed ID: 19323948
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.
    Pattery T; Verlinden Y; De Wolf H; Nauwelaers D; Van Baelen K; Van Houtte M; Mc Kenna P; Villacian J
    Intervirology; 2012; 55(2):138-46. PubMed ID: 22286884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and genotypic testing in clinical practice.
    Holodniy M
    AIDS Patient Care STDS; 1998 Jul; 12(7):527-31. PubMed ID: 15462003
    [No Abstract]   [Full Text] [Related]  

  • 6. [The prevalence of HIV-1 drug resistance and associated factors in AIDS patients receiving HAART in Zhecheng county, Henan province].
    Yuan Y; Xing H; Wang XY; Liu CH; Yang LT; Zheng BF; Wang X; Ruan YH; Wang Z; Liu HW; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):619-24. PubMed ID: 22041566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we design drugs for HIV/AIDS that are less susceptible to resistance?
    Weber IT
    Future Med Chem; 2015; 7(17):2301-4. PubMed ID: 26619140
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational approach to AIDS drug design through structural biology.
    Wlodawer A
    Annu Rev Med; 2002; 53():595-614. PubMed ID: 11818491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance between genotypic resistance and pseudovirus phenotypic resistance in AIDS patients after long-term antiretroviral therapy and virological failure.
    Yang J; Geng W; Zhang M; Han X; Shang H
    J Basic Microbiol; 2014 Oct; 54(10):1120-5. PubMed ID: 24338739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapeutic possibilities for human immunodeficiency virus/acquired immunodeficiency syndrome.
    Balint GA
    Pharmacol Ther; 2001 Jan; 89(1):17-27. PubMed ID: 11316511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).
    De Clercq E
    Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 genotypic and phenotypic resistance.
    Hanna GJ
    Clin Lab Med; 2002 Sep; 22(3):637-49. PubMed ID: 12244590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of resistance in the treatment of AIDS: clarification of viral and cellular factors].
    Gröschel B; Spielhofen A; Stürmer M; Cinatl J; Doerr HW
    Dtsch Med Wochenschr; 2001 Nov; 126(44):1249-54. PubMed ID: 11687987
    [No Abstract]   [Full Text] [Related]  

  • 15. Aggressive HIV-1?
    Berkhout B; de Ronde A; van der Hoek L
    Retrovirology; 2005 Feb; 2():13. PubMed ID: 15737238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy].
    Li J; Jiao LY; Li HP; Li L; Liu YJ; Zhuang DM; Liu SY; Bao ZY; Li H; Wang Z; Li JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):794-800. PubMed ID: 19103117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different HIV resistance interpretation by distinct systems on clinical utility of resistance testing.
    De Luca A; Perno CF
    Curr Opin Infect Dis; 2003 Dec; 16(6):573-80. PubMed ID: 14624108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.
    Hupfeld J; Efferth T
    In Vivo; 2009; 23(1):1-6. PubMed ID: 19368117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 drug resistance among untreated patients in India: Current status.
    Pachamuthu B; Shanmugam S; Nagalingeswaran K; Solomon SS; Solomon S; Solomon S
    J Postgrad Med; 2006; 52(3):183-6. PubMed ID: 16855318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of HIV-1 reverse transcriptase.
    Parniak MA; Sluis-Cremer N
    Adv Pharmacol; 2000; 49():67-109. PubMed ID: 11013761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.